The Needless Flap Over Flibanserin

April 2016 -- Misinformation and bias threaten to deprive women of the first FDA-approved treatment for hypoactive sexual desire disorder. Here are the facts about Flibanserin from Dr. Holly L. Thacker.

Read More


Share this article